A Study of 1592U89 in HIV-Infected Children
NCT00002197
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
250
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Abacavir sulfate
Sponsor
Glaxo Wellcome